ACM
SAGE

Aquatic Capital Management’s Sage Therapeutics SAGE Stock Holding History

Aquatic Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,500
Closed -$216K – 1550
2024
Q1 		$216K Sell
11,500
-6,400
-36% -$148K 0.01% 744
2023
Q4 		$388K Buy
17,900
+9,800
+121% +$194K 0.01% 695
2023
Q3 		$167K Buy
8,100
+2,500
+45% +$72.2K 0.01% 720
2023
Q2 		$263K Buy
+5,600
New +$279K 0.01% 597
2022
Q4 		– Sell
-6,400
Closed -$251K – 1764
2022
Q3 		$251K Sell
6,400
-4,400
-41% -$170K 0.02% 560
2022
Q2 		$349K Buy
+10,800
New +$362K 0.11% 216
2022
Q1 		– Sell
-2,000
Closed -$85K – 1463
2021
Q4 		$85K Buy
+2,000
New +$83.7K 0.16% 163

Other funds holding SAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return